Global Respiratory Distress Syndrome Market Research Report 2023(Status and Outlook)
Report Overview
Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.
The Global Respiratory Distress Syndrome Market Size was estimated at USD 377.70 million in 2022 and is projected to reach USD 549.43 million by 2029, exhibiting a CAGR of 5.50% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Respiratory Distress Syndrome market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Respiratory Distress Syndrome Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Respiratory Distress Syndrome market in any manner.
Global Respiratory Distress Syndrome Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Market Segmentation (by Type)
Poractant Alfa
Beractant
Calfactant
Others
Market Segmentation (by Application)
Rx Drug
OTC Drug
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Respiratory Distress Syndrome Market
Overview of the regional outlook of the Respiratory Distress Syndrome Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Respiratory Distress Syndrome
- 1.2 Key Market Segments
- 1.2.1 Respiratory Distress Syndrome Segment by Type
- 1.2.2 Respiratory Distress Syndrome Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Respiratory Distress Syndrome Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Respiratory Distress Syndrome Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Respiratory Distress Syndrome Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Respiratory Distress Syndrome Market Competitive Landscape
- 3.1 Global Respiratory Distress Syndrome Sales by Manufacturers (2018-2023)
- 3.2 Global Respiratory Distress Syndrome Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Respiratory Distress Syndrome Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Respiratory Distress Syndrome Sales Sites, Area Served, Product Type
- 3.6 Respiratory Distress Syndrome Market Competitive Situation and Trends
- 3.6.1 Respiratory Distress Syndrome Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Respiratory Distress Syndrome Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Respiratory Distress Syndrome Industry Chain Analysis
- 4.1 Respiratory Distress Syndrome Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Respiratory Distress Syndrome Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Respiratory Distress Syndrome Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Respiratory Distress Syndrome Sales Market Share by Type (2018-2023)
- 6.3 Global Respiratory Distress Syndrome Market Size Market Share by Type (2018-2023)
- 6.4 Global Respiratory Distress Syndrome Price by Type (2018-2023)
- 7 Respiratory Distress Syndrome Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Respiratory Distress Syndrome Market Sales by Application (2018-2023)
- 7.3 Global Respiratory Distress Syndrome Market Size (M USD) by Application (2018-2023)
- 7.4 Global Respiratory Distress Syndrome Sales Growth Rate by Application (2018-2023)
- 8 Respiratory Distress Syndrome Market Segmentation by Region
- 8.1 Global Respiratory Distress Syndrome Sales by Region
- 8.1.1 Global Respiratory Distress Syndrome Sales by Region
- 8.1.2 Global Respiratory Distress Syndrome Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Respiratory Distress Syndrome Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Respiratory Distress Syndrome Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Respiratory Distress Syndrome Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Respiratory Distress Syndrome Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Respiratory Distress Syndrome Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 Chiesi Farmaceutici
- 9.1.1 Chiesi Farmaceutici Respiratory Distress Syndrome Basic Information
- 9.1.2 Chiesi Farmaceutici Respiratory Distress Syndrome Product Overview
- 9.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Product Market Performance
- 9.1.4 Chiesi Farmaceutici Business Overview
- 9.1.5 Chiesi Farmaceutici Respiratory Distress Syndrome SWOT Analysis
- 9.1.6 Chiesi Farmaceutici Recent Developments
- 9.2 CR-Double Crane
- 9.2.1 CR-Double Crane Respiratory Distress Syndrome Basic Information
- 9.2.2 CR-Double Crane Respiratory Distress Syndrome Product Overview
- 9.2.3 CR-Double Crane Respiratory Distress Syndrome Product Market Performance
- 9.2.4 CR-Double Crane Business Overview
- 9.2.5 CR-Double Crane Respiratory Distress Syndrome SWOT Analysis
- 9.2.6 CR-Double Crane Recent Developments
- 9.3 ONY Biotech
- 9.3.1 ONY Biotech Respiratory Distress Syndrome Basic Information
- 9.3.2 ONY Biotech Respiratory Distress Syndrome Product Overview
- 9.3.3 ONY Biotech Respiratory Distress Syndrome Product Market Performance
- 9.3.4 ONY Biotech Business Overview
- 9.3.5 ONY Biotech Respiratory Distress Syndrome SWOT Analysis
- 9.3.6 ONY Biotech Recent Developments
- 9.4 AbbVie
- 9.4.1 AbbVie Respiratory Distress Syndrome Basic Information
- 9.4.2 AbbVie Respiratory Distress Syndrome Product Overview
- 9.4.3 AbbVie Respiratory Distress Syndrome Product Market Performance
- 9.4.4 AbbVie Business Overview
- 9.4.5 AbbVie Respiratory Distress Syndrome SWOT Analysis
- 9.4.6 AbbVie Recent Developments
- 9.5 Yuhan Corporation
- 9.5.1 Yuhan Corporation Respiratory Distress Syndrome Basic Information
- 9.5.2 Yuhan Corporation Respiratory Distress Syndrome Product Overview
- 9.5.3 Yuhan Corporation Respiratory Distress Syndrome Product Market Performance
- 9.5.4 Yuhan Corporation Business Overview
- 9.5.5 Yuhan Corporation Respiratory Distress Syndrome SWOT Analysis
- 9.5.6 Yuhan Corporation Recent Developments
- 9.6 JW Pharmaceuticals
- 9.6.1 JW Pharmaceuticals Respiratory Distress Syndrome Basic Information
- 9.6.2 JW Pharmaceuticals Respiratory Distress Syndrome Product Overview
- 9.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Product Market Performance
- 9.6.4 JW Pharmaceuticals Business Overview
- 9.6.5 JW Pharmaceuticals Recent Developments
- 9.7 Noargen
- 9.7.1 Noargen Respiratory Distress Syndrome Basic Information
- 9.7.2 Noargen Respiratory Distress Syndrome Product Overview
- 9.7.3 Noargen Respiratory Distress Syndrome Product Market Performance
- 9.7.4 Noargen Business Overview
- 9.7.5 Noargen Recent Developments
- 10 Respiratory Distress Syndrome Market Forecast by Region
- 10.1 Global Respiratory Distress Syndrome Market Size Forecast
- 10.2 Global Respiratory Distress Syndrome Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Respiratory Distress Syndrome Market Size Forecast by Country
- 10.2.3 Asia Pacific Respiratory Distress Syndrome Market Size Forecast by Region
- 10.2.4 South America Respiratory Distress Syndrome Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Respiratory Distress Syndrome by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Respiratory Distress Syndrome Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Respiratory Distress Syndrome by Type (2024-2029)
- 11.1.2 Global Respiratory Distress Syndrome Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Respiratory Distress Syndrome by Type (2024-2029)
- 11.2 Global Respiratory Distress Syndrome Market Forecast by Application (2024-2029)
- 11.2.1 Global Respiratory Distress Syndrome Sales (K Units) Forecast by Application
- 11.2.2 Global Respiratory Distress Syndrome Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook